Frequency and Factors Associatedwith Adverse Reactions followingthe Administration of Influenza Vaccinein Personal Health duringthe 2009-2010 Season;Frecuencia de reacciones adversas y factores asociadostras laadministración de lavacunade lagripe en personalsanitario durante la temporada 2009-2010

Revista Espanola de Salud Publica

Volumn 84, Issue 6, 2010, Pages 851-859

  Sánchez Payá, José ^a   Hernández García, Ignacio ^b   Barrenengoa Sañudo, Julio ^a   Camargo Angeles, Robert ^a   Rincon, Angela ^a   Romero Candeira, Santiago ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Adverse Effects; Health Personnel; Influenza Vaccines

Indexed keywords

INFLUENZA VACCINE;

ADULT; ARTICLE; COHORT ANALYSIS; DRUG TOXICITY; FEMALE; HEALTH CARE PERSONNEL; HUMAN; MALE; MIDDLE AGED; VACCINATION;

ADULT; COHORT STUDIES; DRUG TOXICITY; FEMALE; HEALTH PERSONNEL; HUMANS; INFLUENZA VACCINES; MALE; MIDDLE AGED; VACCINATION;

EID: 79951792135     PISSN: 11355727     EISSN: 16969820     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Stewart AM. Mandatory vaccination of health care workers. N Engl J Med. 2009;361:2015-7.
2. Carman WF, Elder AG, Wallace LA, McAulay K, Walker A, Murray GD, et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet. 2000;355:93-7. (Pubitemid 30068552)
3. Maltezou HC, Maragos A, Katerelos P, Paisi A, Karageorgou K, Papadimitriou T, et al. Influenza vaccination acceptance among health-care workers: a nationwide survey. Vaccine 2008;26:1408-10.
4. Galicia-García MD, González-Torga A, García- González C, Fuster-Pérez M, Garrigós-Gordo I, López-Fresneña N, et al. Vacunación de gripe en trabajadores sanitarios. Por qué se vacunan y por qué no se vacunan. Enferm Infecc Microbiol Clin. 2006;24:413-7.
5. Gazmararian JA, Coleman M, Prill M, Hinman AR, Ribner BS, Washington ML, et al. Influenza vaccination of health care workers: policies and practices of hospitals in a community setting. Am J Infect Control. 2007;35:441-7. (Pubitemid 47331964)
6. Lindley MC, Yonek J, Ahmed F, et al. Measurement of influenza vaccination coverage among healthcare personnel in US hospitals. Infect Control Hosp Epidemiol. 2009;30:1150-7.
7. Pearson ML, Bridges CB, Harper SA; Healthcare Infection Control Practices Advisory Committee (HICPAC); Advisory Committee on Immunization Practices (ACIP). Influenza vaccination of healthcare personnel: recommendations of the Healthcare Infection Control Practices Advisory Committee (HICPAC) and the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55:1-16.
8. National Center for Immunization and Respiratory Diseases, CDC; Centers for Disease Control and Prevention (CDC). Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep. 2009;58:1-8.
9. European Centre for Disease Prevention and Control. ECDC Interim Guidance. Use of specific pandemic influenza vaccines during the H1N1 2009 pandemic. Stockholm: European Centre for Disease Prevention and Control; 2009.
10. Información general Gripe A. Madrid: Ministerio de Sanidad y Política Social [consultado 8/12/2009]. Disponible en: http://www.informaciongripea.es.
11. Hernández-García I, García-Iglesias MA, López-García E, Sáenz-González MC. Características epidemiológicas de los pacientes hospitalizados por gripe causada por virus influenza A(H1N1) 2009 [en prensa].
12. Clark TW, Pareek M, Hoschler K, Dillon H, Nicholson KG, Groth N, et al. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N Engl J Med. 2009;361:2424-35.
13. Liang XF, Wang HQ, Wang JZ, Fang HH, Wu J, Zhu FC, et al. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebocontrolled trial. Lancet. 2010;375:56-66.
14. Plennevaux E, Sheldon E, Blatter M, Reeves-Hoché MK, Denis M. Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials. Lancet. 2010;375:41-8.
15. Roman F, Vaman T, Gerlach B, Markendorf A, Gillard P, Devaster JM. Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial. Vaccine. 2010;28:1740-5.
16. Zhu FC, Wang H, Fang HH, Yang JG, Lin XJ, Liang XF, et al. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med. 2009; 361:2414-23.
17. Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J, et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med. 2009;361:2405-13.
18. Hernández-García I, Haro-Pérez AM, González-Celador R, Sáenz-González MD. Efectos adversos de la vacuna frente al nuevo virus influenza A (H1N1) en pacientes [en prensa].
19. Hernández-García I, Sánchez-Payá J, Camargo R, Barrenengoa J, Martínez H, González-Torga A. Frecuencia de reacciones adversas de la vacuna antigripal en personal sanitario de un hospital universitario en España. Enferm Infecc Microbiol Clin. 2010; 28(7):435-8.
20. Centers for Disease Control and Prevention (CDC). Interim results: influenza A (H1N1) 2009 monovalent and seasonal influenza vaccination coverage among health-care personnel - United States, August 2009-January 2010. MMWR Morb Mortal Wkly Rep. 2010;59:357-62.
21. Poland GA, Johnson DR. Increasing influenza vaccination rates: the need to vaccinate throughout the entire influenza season. Am J Med. 2008;121:S3-10. (Pubitemid 351876193)
22. Babcock HM, Gemeinhart N, Jones M, Dunagan WC, Woeltje KF. Mandatory influenza vaccination of health care workers: translating policy to practice. Clin Infect Dis. 2010;50:459-64.
23. Kara A, Devrim I, Celik T,Akca T,Tezer H, Simsek OP, et al. Influenza vaccine adverse event and effect on acceptability in pediatric residents. Jpn J Infect Dis 2007;60:387-8. (Pubitemid 350177146)
24. Lopes MH, Mascheretti M, Franco MM, Vasconcelos R, Gutierrez EB. Occurrence of early adverse events after vaccination against influenza at a Brazilian reference center. Clinics (Sao Paulo). 2008;63:21-6.
25. Scheifele DW, Bjornson G, Johnston J. Evaluation of adverse events after influenza vaccination in hospital personnel. CMAJ. 1990;142:127-30. (Pubitemid 20039263)
26. Lee CS, Lee KH, Jung MH, Lee HB. Rate of influenza vaccination and its adverse reactions seen in health care personnel in a single tertiary hospital in Korea. Jpn J Infect Dis. 2008; 61:457-60.
27. Centers for Disease Control and Prevention (CDC). Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009. MMWR Morb Mortal Wkly Rep. 2009;58:1351-6.
28. Dinh A, Lawrence C, Salomon J, Descatha A. Expected and unexpected adverse effects H1N1 vaccination for health care workers in a university hospital. Vaccine. 2010;28:2063.